Search Results - "RAYMAKERS, Reinier"
-
1
Acquired mutations in TET2 are common in myelodysplastic syndromes
Published in Nature genetics (01-07-2009)“…Myelodysplastic syndromes (MDS) represent a heterogeneous group of neoplastic hematopoietic disorders. Several recurrent chromosomal aberrations have been…”
Get full text
Journal Article -
2
From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells
Published in Cancer research (Chicago, Ill.) (15-05-2018)“…Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone marrow (BM). It represents the final stage in a continuum of…”
Get full text
Journal Article -
3
CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis
Published in Virchows Archiv : an international journal of pathology (01-05-2024)“…The classical BCR::ABL1 -negative myeloproliferative neoplasms (MPN) form a group of bone marrow (BM) diseases with the potential to progress to acute myeloid…”
Get full text
Journal Article -
4
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
Published in Journal of hematology and oncology (18-05-2018)“…Multiple myeloma is the second most frequent hematological malignancy in the western world and remains incurable, predominantly due to acquired drug resistance…”
Get full text
Journal Article -
5
Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis
Published in Blood (19-06-2014)“…During recent years, our understanding of the pathogenesis of inherited microcytic anemias has gained from the identification of several genes and proteins…”
Get full text
Journal Article -
6
Anemia in Hodgkin's Lymphoma: The Role of Interleukin-6 and Hepcidin
Published in Journal of clinical oncology (20-05-2010)“…Cytokines play a pivotal role in Hodgkin's lymphoma (HL). Because interleukin-6 (IL-6) induces expression of hepcidin, one of the principal regulators of iron…”
Get full text
Journal Article -
7
CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis
Published in Journal of cell communication and signaling (01-03-2021)“…CCN2, formerly termed Connective Tissue Growth Factor, is a protein belonging to the Cellular Communication Network (CCN)-family of secreted extracellular…”
Get full text
Journal Article -
8
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity
Published in PLoS pathogens (01-03-2009)“…Immunoglobulin A (IgA) secretion by plasma cells in the immune system is critical for protecting the host from environmental and microbial infections. However,…”
Get full text
Journal Article -
9
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis
Published in The Lancet. Haematology (01-04-2017)“…Summary Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after allogeneic haemopoietic cell transplantation (HCT)…”
Get full text
Journal Article -
10
Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
Published in Journal of clinical oncology (20-08-2012)“…We investigated whether bortezomib during induction and maintenance improves survival in newly diagnosed multiple myeloma (MM). In all, 827 eligible patients…”
Get full text
Journal Article -
11
Functional differences between mesenchymal stem cell populations are reflected by their transcriptome
Published in Stem cells and development (01-04-2010)“…Stem cells are widely studied to enable their use in tissue repair. However, differences in function and differentiation potential exist between distinct stem…”
Get more information
Journal Article -
12
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Published in Blood (28-07-2016)“…Patients with relapsed and/or refractory multiple myeloma (RRMM) have poor prognosis. The STRATUS study assessed safety and efficacy of pomalidomide plus…”
Get full text
Journal Article -
13
Quantitative characterization of immune cells by measuring cellular signal transduction pathway activity
Published in Scientific reports (18-10-2024)“…For many diseases, including cancer, infections, and auto-immune diseases, the immune response is a major determinant of disease progression, response to…”
Get full text
Journal Article -
14
Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands
Published in Blood (22-03-2018)Get full text
Journal Article -
15
Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1
Published in Cancers (17-09-2021)“…Multiple myeloma (MM) is a hematological malignancy that is still considered incurable due to the development of therapy resistance and subsequent relapse of…”
Get full text
Journal Article -
16
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
Published in The Lancet. Haematology (01-04-2017)“…Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can…”
Get full text
Journal Article -
17
EBV-related lymphoma after long-term daratumumab treatment: a case report
Published in Blood cancer journal (New York) (04-11-2020)Get full text
Journal Article -
18
A Critical Role for Prostaglandin E2 in Podosome Dissolution and Induction of High-Speed Migration during Dendritic Cell Maturation
Published in The Journal of immunology (1950) (01-08-2006)“…Dendritic cells (DCs) are professional APCs of the immune system that play a key role in regulating T cell-based immunity. The capacity of DCs to activate T…”
Get full text
Journal Article -
19
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-01-2019)“…Lenalidomide has been proven to be effective but with a distinct and difficult to manage toxicity profile in the context of chronic lymphocytic leukemia,…”
Get full text
Journal Article -
20
Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review
Published in British journal of haematology (01-07-2013)“…Summary This systematic review of studies compared magnetic resonance imaging (MRI), 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET), FDG‐PET…”
Get full text
Journal Article